explore
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: Roivant's CEO is a star, but biotech's black hole persists
Next article: Roivant's CEO is a star, but biotech's black hole persists
entertainment
hotspot
-
STAT Readout Newsletter: Biotech news today
2025-09-28 02:22 -
Study on Amgen’s bispecific immunotherapy produces positive data
2025-09-28 02:13 -
STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots
2025-09-28 01:22 -
ADCs take center stage as promising cancer treatments
2025-09-28 01:12 -
Roivant's CEO is a star, but biotech's black hole persists
2025-09-28 01:11 -
Why a market frenzy over new weight loss drugs defies logic
2025-09-28 00:05